To explore the role of endothelial cell dysfunction in post-transplant complications following allogeneic stem cell transplantation (alloSCT), highlighting its significance for patient outcomes.
Key Findings:
Endothelial dysfunction can lead to severe complications such as VOD/SOS, TA-TMA, and refractory acute GVHD, impacting patient survival.
Biomarkers like ANG2 and ST2 are significant for predicting and diagnosing endothelial injury syndromes, with potential for guiding treatment.
Functional heterogeneity among endothelial cells complicates the establishment of diagnostic criteria for endothelial complications, necessitating further research.
Interpretation:
Endothelial cell dysfunction is a critical factor influencing the outcomes of alloSCT, necessitating further research into biomarkers and individualized patient management strategies.
Limitations:
Diverse patient responses complicate the identification of universal diagnostic criteria, highlighting the need for personalized approaches.
Current biomarkers may not capture the full spectrum of endothelial dysfunction, indicating a gap in diagnostic capabilities.
Conclusion:
Understanding endothelial cell dysfunction and its biomarkers is essential for improving outcomes in patients undergoing alloSCT, underscoring the urgency for further research.
